CryoLife, Inc. (NYSE:CRY)
| CAPS Rating |
|
|---|---|
| Open | $5.67 |
| Previous Close | $5.75 |
| Daily Range | $5.61 - $5.74 |
| 52-Week Range | $4.00 - $6.17 |
| Market Cap | $159.09M |
| P/E Ratio | 44.90 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 25,450 |
| Average Daily Volume | 0 |
CRY
VS S&P 500 (SPY)
How do you think CRY will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
CRY Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
CRY News and Commentary
- CryoLife Earnings Preview – The Motley Fool
- CryoLife's CEO Discusses Q2 2011 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- CryoLife's CEO Discusses Q1 2011 Results - Earnings Call Transcript – SeekingAlpha
- CryoLife's CEO Discusses Q1 2011 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- Closing Bell: Cautious Euphoria Continues (AMZN, APOL, CRY, GFRE, HD, TM) – BloggingStocks
- CryoLife CEO Discusses Q4 2010 Results - Earnings Call Transcript – SeekingAlpha
- CryoLife CEO Discusses Q4 2010 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- Global Capital Buys 80% Stake In Turkish Medical Company – SmartMoney
- Evidence that past returns correlate with future returns (written by a fundamental investor) – Blog at The Motley Fool
- Best and Worst Performing Stocks Since Lehman Bankruptcy – SeekingAlpha
- CryoLife CEO Discusses Q3 2010 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- CryoLife CEO Discusses Q3 2010 Results - Earnings Call Transcript – SeekingAlpha
- Will Orthovita Fall Short Next Quarter? – The Motley Fool
- CryoLife, Inc. Q2 2010 Earnings Call Transcript – SeekingAlpha Transcripts
- CryoLife, Inc. Q2 2010 Earnings Call Transcript – SeekingAlpha
- Analyst Calls: STI, BIDU, BAX, JBLU, TRV, SNDK, AGN, COO, BEC – BloggingStocks
- CryoLife Shares Up on FDA Heart Valve Ruling – Fox Business
- CryoLife Gains On FDA Nod Extending Heart Valve's Shelf Life – SmartMoney
- 5-Star Stocks Poised to Pop: CryoLife – The Motley Fool
- UPDATE 1-CryoLife says Medafor rejects its $2/shr offer – Reuters
RSS Headlines
Fool UK
